login
login
Image header Agence Europe
Europe Daily Bulletin No. 13655
Contents Publication in full By article 12 / 35
SECTORAL POLICIES / Health

EU grants conditional authorisation for drug to treat Duchenne muscular dystrophy

On Friday 6 June, the European Commission issued a conditional EU marketing authorisation for givinostat (Duvyzat), a drug designed to treat Duchenne muscular dystrophy.

There is currently no cure for this rare genetic disease, characterised by progressive muscle weakness and deterioration, mainly in children.

Authorisation is based on a positive scientific assessment by the European Medicines Agency (EMA).

The EMA concluded that, although all the data is not yet available, the benefits to...

Contents

SECTORAL POLICIES
SOCIAL AFFAIRS
EXTERNAL ACTION
INSTITUTIONAL
FUNDAMENTAL RIGHTS - SOCIETAL ISSUES
COUNCIL OF EUROPE
ECONOMY - FINANCE - BUSINESS
COURT OF JUSTICE OF THE EU
NEWS BRIEFS